Reasons why are Mesothelioma Settlements so High
by on Sunday, May 27th, 2012 | No Comments
Cancer News
- Bladder Cancer (65)
- Brain Tumor Cancer (38)
- Breast Cancer (8038)
- Cancer Bulletins (543)
- Cancer Clinical Trials (5106)
- Cancer Treatment (1204)
- Colon Rectal Cancer (5952)
- General Cancer (16851)
- Leukemia Lymphoma Cancer (10579)
- Lung Mesothelioma Asbestos (4830)
- Ovarian Cervical Uterine Cancer (1143)
- Pancreatic Cancer (56)
- Prostate Cancer (6895)
- Skin Cancer (6033)
- Uncategorized (53)
-
Cancer News Topics
- GRACEcast151_Lung_Dr. Kratz on Prognosis of Early Lung Cancer – Part 2
- Breast & Ovarian Cancer Gene Testing: The New Trend for High Risk Patients
- Tai Chi Tuesday Remembering Sarah Feather ( Ovarian Cancer Awareness Series 3 )
- Dr. Swords and Advanced Leukemia Care
- AIM Global Product Testimonial – Leukemia Survivor
- Fighting Ovarian Cancer With Gold Nanoparticles
- CT detects twice as many lung cancers as X-ray
- Boosting body’s natural flu killers as way to offset virus mutation problem
- American Cancer Society Turns 100, Cancer Incidents in U.S. Trending Downward
- Bollywood Actress Manisha Koirala Vows to Inspire Those Fighting Cancer
- Key Find for Early Bladder Cancer Treatment
- H. pylori, smoking trends, and gastric cancer in U.S. men
- Inflammatory bowel disease raises risk of melanoma
- NIH researchers conduct first genomic survey of human skin fungal diversity; Location on the body surface determines fungal composition with the greatest diversity on feet
- Reducing Your Risk Of Breast Cancer
- Researchers Develop Model For Better Testing, Targeting Of MPNST
- Minimizing Hair Loss Due To Cancer Radiation Therapy
- Grapefruit-Derived Nanovectors Provide A Secret Weapon In Medical Drug Delivery
- Mesothelioma Survivor Finds “Adrenaline Rush” Can be Managed with Medication
- Lung Cancers: New Understanding, New Therapies, New Hope
- Terminal Cancer Patient Disease-Free: Macrobiotic Diet the Cure
- Can Financial Innovation Unlock a Cure for Cancer?
- First genomic survey of human skin fungal diversity
- Study details genes that control whether tumors adapt or die when faced with p53 activating drugs
- Promising new approach to treatment of lung cancer